Primecap Management
ABBV icon

Primecap Management’s AbbVie ABBV Stock Holding History

Primecap Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-14,000
Closed -$1.32M – 293
2018
Q1 		$1.32M Hold
14,000
– – ﹤0.01% 278
2017
Q4 		$1.35M Sell
14,000
-40,000
-74% -$3.77M ﹤0.01% 277
2017
Q3 		$4.8M Sell
54,000
-631,745
-92% -$48.1M ﹤0.01% 250
2017
Q2 		$49.7M Sell
685,745
-140,600
-17% -$9.45M 0.04% 177
2017
Q1 		$53.8M Sell
826,345
-75,500
-8% -$4.75M 0.05% 161
2016
Q4 		$56.5M Sell
901,845
-52,000
-5% -$3.17M 0.06% 153
2016
Q3 		$60.2M Sell
953,845
-26,000
-3% -$1.68M 0.06% 153
2016
Q2 		$60.7M Sell
979,845
-43,000
-4% -$2.62M 0.06% 152
2016
Q1 		$58.4M Sell
1,022,845
-142,200
-12% -$7.93M 0.06% 156
2015
Q4 		$69M Sell
1,165,045
-1,346,900
-54% -$77.6M 0.07% 150
2015
Q3 		$137M Sell
2,511,945
-287,375
-10% -$18.7M 0.15% 114
2015
Q2 		$188M Sell
2,799,320
-931,516
-25% -$60.8M 0.19% 103
2015
Q1 		$218M Sell
3,730,836
-2,848,050
-43% -$172M 0.21% 93
2014
Q4 		$431M Buy
6,578,886
+124,050
+2% +$7.82M 0.44% 61
2014
Q3 		$373M Buy
6,454,836
+150,714
+2% +$8.37M 0.4% 65
2014
Q2 		$356M Sell
6,304,122
-31,600
-0.5% -$1.66M 0.39% 68
2014
Q1 		$326M Buy
6,335,722
+485,052
+8% +$24.5M 0.37% 72
2013
Q4 		$309M Sell
5,850,670
-41,877
-0.7% -$2.06M 0.37% 69
2013
Q3 		$264M Sell
5,892,547
-86,700
-1% -$3.84M 0.35% 74
2013
Q2 		$247M Buy
+5,979,247
New +$262M 0.35% 72

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Primecap Management's ABBV Position: Q2 2018 in Review

Primecap Management sold out of AbbVie (ABBV) in Q2 2018, closing a stake of 14,000 shares — an estimated $1.32M sold.

Primecap Management first reported a position in ABBV in Q2 2013 and held it in 20 quarters. The position peaked at $431M in Q4 2014. 1,996 funds tracked by Wall St. Rank hold ABBV as of Q2 2018.

  • Primecap Management reported no remaining AbbVie position as of Q2 2018 after selling out during the quarter.
  • Primecap Management sold 14,000 AbbVie shares in Q2 2018, an estimated $1.32M.
  • Primecap Management first reported a position in AbbVie in Q2 2013 and held it in 20 quarters.
  • Primecap Management's AbbVie position peaked at $431M in Q4 2014.
  • 1,996 funds tracked by Wall St. Rank held AbbVie as of Q2 2018.

Based on Primecap Management's 13F filing for Q2 2018, filed 13 Aug 2018.